User contributions for Edison

Search for contributionsExpandCollapse
⧼contribs-top⧽
⧼contribs-date⧽

30 June 2022

28 June 2022

24 June 2022

23 June 2022

22 June 2022

21 June 2022

  • 23:5023:50, 21 June 2022 diff hist +38,890 N Scandion OncologyCreated page with "== Summary == '''Scandion Oncology is a Danish biotechnology company that specialises in developing drugs to reverse chemotherapy resistance. Its lead asset, SCO-101, is being investigated as an add-on therapy to existing treatments in metastatic colorectal cancer (mCRC) and unresectable pancreatic cancer (PC). Management’s clinical programme is spearheaded by the Phase II CORIST study in FOLFIRI-resistant mCRC, from which we expect crucial proof-of-concept results in..." Tag: Visual edit

10 June 2022